Berlin
Germany
18
2026-04-02
The entities that hold a legal rights for patent applications filed by inventor DAMES Sibylle:
Sibylle DAMES from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
DOUBLE-STRANDED RNAI AGENTS AND COMPOSITIONS FOR REDUCING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND METHODS OF USE THEREOF
#2 | 2026-03-19NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL
#3 | 2025-07-17Nucleic acids for inhibiting expression of MASP-2 in a cell
#4 | 2025-05-01NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF COMPLEMENT FACTOR B (CFB) IN A CELL
#5 | 2024-10-03NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL
#6 | 2024-07-18SIRNA TARGETING TMPRSS6 FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS
#7 | 2024-07-11NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF CNNM4 IN A CELL
#8 | 2023-08-24NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF CNNM4 IN A CELL
#9 | 2023-01-19Nucleic acids for inhibiting expression of PROS1 in a cell
#10 | 2022-09-15Nucleic acids for inhibiting expression of LPA in a cell
#11 | 2022-08-04NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL
#12 | 2022-06-02Nucleic acids for inhibiting expression of LPA in a cell
#13 | 2022-05-05NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL
#14 | 2022-01-27PRODUCTS AND COMPOSITIONS
#15 | 2022-01-20NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF C3 IN A CELL
#16 | 2022-01-06NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL
#17 | 2021-04-29Nucleic acids for inhibiting expression of LPA in a cell
#18 | 2020-07-02Products and compositions
2780288 ⎘